Younghoon Kim
Corneal transplantation, medically termed keratoplasty, is one of the most frequently performed form of transplantation worldwide, and in the UK, it continues to restore sight to thousands of people each year (1). NHS Blood and Transplant (NHSBT) reported 5071 corneal transplants across the UK in 2024/25, a ten-year high, yet donor numbers fell by 3% over the same period to 4976 (2, 3). More than 4000 people in England are currently living with sight loss that a corneal transplant could address, with 500 patients waiting over a year (2). This article sets out the corneal donation pathway, eye banking process, and clinical indications and types of corneal transplants that make use of the donated tissue.
The donation pathway
Corneal donation involves retrieving the whole eye, from which the cornea is subsequently used. Unlike solid organ donors, corneal donors do not need to have died in an intensive care or emergency setting (4). Retrieval can proceed up to 24 hours after death at settings including hospital mortuaries, hospices and funeral directors’ premises (4).
Eligibility
It may understandably be assumed initially that cancer or chronic illness would prevent patients from donating corneas, as is the case for solid organs. The cornea is avascular and immunologically privileged, and therefore, most people who die, including those with most cancers, can donate their eyes (5). Poor eyesight due to cataract does not preclude donation (2). Age is also less restrictive, with the usual upper limit for eye donors being 80 years, although this may be extended depending on national tissue stock levels (6). Key contraindications for corneal donation for the purpose of corneal transplant include (4, 7):
- Dementia or other neurological conditions, including prion disease
- Infections: Human immunodeficiency virus (HIV), Viral hepatitis (B,C,E), Human T-lymphotropic virus (HTLV) or Rabies
- Haematological malignancy or metastatic malignant melanoma
- Intraocular tumours
- Active ocular inflammation
- Previous corneal graft recipient
Despite such contraindications, with specific consent, eyes unsuitable for transplant may instead be used in ethically approved research.
Consent and referral
All four UK nations now operate opt-out systems of deemed consent for organ donations, although individuals may opt out of eye donation specifically (8). For many patients and families, the eyes carry particular emotional or spiritual significance, which can make eye donation harder to consider. Deemed consent, however, does not make donation automatic. A potential donor must first be referred to NHSBT, after which a specialist nurse speaks with the next of kin to confirm the donor’s wishes and take medical history (4). Clinicians’ awareness of patients’ wishes around corneal donation and timely referral is therefore pivotal. Nevertheless, in a national study of 1199 deceased patients in hospice and hospital palliative care settings, while 46 % of patients were eligible for eye donation, the option was raised with families in only 3% of eligible cases (5). Many patients may never have had the opportunity to give the gift of sight, and involving patients in the conversation sensitively and appropriately is important.
Retrieval
Trained teams perform enucleation of the eyes and take a blood sample for serological screening of the deceased. Care is taken to immediately reconstruct with an ocular prosthesis so that the donor’s appearance is unaffected (4).
Eye Banking
In the UK, corneal tissue is processed by NHSBT Tissue and Eye Services at its two national eye banks in Bristol and Liverpool (3). There are also hospital-based eye banks, such as those at Moorfields Eye Hospital in London and Queen Victoria Hospital in East Grinstead (6, 9). Supply pressures are now such that some centres import corneal tissue from overseas eye banks to meet demand (8).
Donor corneas are stored in one of two ways. Hypothermic storage at 2 to 8 degrees Celsius preserves tissue for up to two weeks and is mainly used in the United States and Asia, whereas organ culture at 31 to 37 degrees Celsius allows storage for up to four weeks and is more widely used in the UK and Europe (10). Before release, organ-cultured corneas are transferred to dextran-containing medium to reverse the stromal swelling that develops during storage (11).
The health of the corneal endothelium is a key measure of tissue quality. In most eye banks, corneas are considered suitable for transplantation only if the central endothelial cell density (ECD) is at least 2000 – 2500 (cells/mm2) (12). The exact threshold is set by each institution and may differ between graft types. In the UK, the minimum ECD for a full thickness corneal transplant (penetrating keratoplasty) is 2200 (cells/mm2) (13).
Endothelial grafts, which replace only the inner layer of the cornea, are thin and delicate. They may be dissected by a surgeon in theatre, or supplied by the eye bank pre-cut or pre-loaded into an injector (14). Eye bank preparation may shorten theatre time, avoid losing tissue if dissection fails, and allow the graft to be quality-checked before release, but at a higher cost (14). Practice therefore varies between centres.
Types of keratoplasty
Keratoplasty can be full-thickness or lamellar, the latter replacing only the diseased layers of the cornea. Lamellar techniques now account for the majority of corneal transplants performed in the UK (15).
Penetrating keratoplasty (PK) replaces the full thickness of the cornea with a donor button sutured into place. It remains necessary when disease affects every layer, as with dense full-thickness scarring, and may be used for regrafts (15). Visual recovery may be slower than after lamellar grafts, and sutures can cause irregular astigmatism (16).
Deep anterior lamellar keratoplasty (DALK) replaces the front layers of the cornea while keeping the patient’s own Descemet membrane and endothelium. It suits conditions that spare the endothelium, most notably keratoconus (15).
Endothelial keratoplasty (EK) replaces only the diseased inner layer. It is the preferred approach for endothelial failure, as in Fuchs endothelial dystrophy and pseudophakic bullous keratopathy (15). The graft is inserted through a small incision and held against the posterior cornea by an air or gas bubble (17). There are two main forms:
- Descemet stripping automated endothelial keratoplasty (DSAEK) transplants the endothelium with a thin layer of supporting stroma.
- Descemet membrane endothelial keratoplasty (DMEK) transplants only Descemet membrane and endothelium. It is thinner and more technically demanding, and is now the most frequently performed corneal transplant in the UK, accounting for 41% of all keratoplasties performed in 2025/26 (18).
Outcomes and complications
Since 1999, the UK Transplant Registry has collected follow-up data on over 100,000 corneal transplants (19). Corneal transplantation is one of the most successful forms of transplantation, although outcomes vary with the indication (20). For first grafts performed in 2018-2020 in the UK, five-year graft survival was 89% for keratoconus, 81% for Fuchs endothelial dystrophy, and 64% for pseudophakic bullous keratopathy (18).
The most important complication is endothelial rejection. It is serious because endothelial cells do not regenerate, so cells lost during a rejection episode can lead to corneal oedema and graft failure (15). Rejection typically presents with redness, sensitivity to light, reduced vision and pain (“RSVP”), with keratic precipitates on the graft, and requires urgent treatment with topical steroids.
Other complications include (15):
- Late endothelial failure
- Raised intraocular pressure, often steroid-induced
- Infection
- Recurrence of the original disease
- Refractive error, particularly astigmatism after PK
- Graft detachment after EK, which may require a further air injection (re-bubbling)
Patients need long-term follow-up and clear advice to seek help urgently if RSVP symptoms develop.
Conclusion
Corneal transplantation in the UK operates on a connected pathway from donation through eye banking to keratoplasty. Surgical practice has shifted towards lamellar techniques where appropriate, with DMEK now the most frequently performed keratoplasty. As in many countries, the availability of donor tissue remains the primary factor limiting access to keratoplasty. Every donation begins with the generosity of a donor and their family, and clinicians who are familiar with the eligibility criteria and referral process are well placed to offer patients and families the opportunity to give the gift of sight.
References
1. Dorado Cortez O, Poinard S, Gain P, et al. Ten-year update of a global survey of corneal transplant and eye banking. JAMA Ophthalmol. 2026. doi: 10.1001/jamaophthalmol.2026.4147.
2. NHS Blood and Transplant. Thousands of people are needlessly living with sight loss because of a shortage of donors [Internet]. 2025. Available from: https://www.organdonation.nhs.uk/news/thousands-of-people-are-needlessly-living-with-sight-loss-because-of-a-shortage-of-donors/. (Accessed: 27 October 2026).
3. University of Bristol. Eye bank celebrates 40 years of sight saving work [Internet]. 2026. Available from: https://www.bristol.ac.uk/news/2026/march/eye-bank-celebrates-40-years-of-sight-saving-work.html. (Accessed: 27 October 2026).
4. Walding J, Evans L, Seaman S. The gift of sight: normalising discussions and referral for corneal donation in the inpatient setting. Br J Hosp Med (Lond). 2020;81(3):1-6.
5. Long-Sutehall T, Madi-Segwagwe BC, Hurlow A, et al. The potential for eye donation from hospice and palliative care clinical settings in England: a retrospective case note review of deceased patients’ records. Cell Tissue Bank. 2023;24(2):341-9.
6. Queen Victoria Hospital NHS Foundation Trust. Gift of sight [Internet]. 2026. Available from: https://www.qvh.nhs.uk/for-patients/giftofsight/. (Accessed: 27 October 2026).
7. Joint Professional Advisory Committee to the UK Blood Transfusion and Tissue Transplantation Services. Tissue (deceased donors) [Internet]. 2026. Available from: https://www.jpac.org.uk/guidelines/td/. (Accessed: 27 October 2026).
8. Edwards A, Ao J, Bridson JD, Kaye SB. Why take the eye? A systematic review of corneal retrieval methods and donor consent: implications for the UK. BMJ Open Ophthalmol. 2025;10(1):e002372.
9. Moorfields Eye Hospital NHS Foundation Trust. Eye organ donor – Yes Eye Can [Internet]. Available from: https://www.moorfields.nhs.uk/for-patients/eye-bank. (Accessed: 27 October 2026).
10. Cipolla J, Jo M, Sabater AL. A comprehensive review of donor corneal preservation strategies. Cornea. 2024;43(11):1456-65.
11. Armitage WJ. Preservation of human cornea. Transfus Med Hemother. 2011;38(2):143-7.
12. Amir E, Lichter DD, Corem N, Solomon A. Clinical and epidemiological factors affecting donor corneal endothelial cell density. BMJ Open Ophthalmol. 2025;10(1):e002399.
13. Wakefield MJ, Armitage WJ, Jones MNA, et al. The impact of donor age and endothelial cell density on graft survival following penetrating keratoplasty. Br J Ophthalmol. 2016;100(7):986-9.
14. Pagano L, Gadhvi KA, Parekh M, et al. Cost analysis of eye bank versus surgeon prepared endothelial grafts. BMC Health Serv Res. 2021;21(1):801.
15. Liu S, Wong YL, Walkden A. Current perspectives on corneal transplantation. Clin Ophthalmol. 2022;16:631-46.
16. Wilhelm TI, Gauché L, Böhringer D, et al. Ten-year outcomes after DMEK, DSAEK, and PK: insights on graft survival, endothelial cell density loss, rejection and visual acuity. Sci Rep. 2025;15(1):1249.
17. Aggarwal S, Kumari M, Bhatnagar N. Advancements in keratoplasty: exploring newer techniques and imaging modalities for enhanced surgical outcomes. Saudi J Ophthalmol. 2025;39(4):337-48.
18. NHS Blood and Transplant. Organ and tissue donation and transplantation activity report 2025/26 [Internet]. 2026. Available from: https://nhsbtdbe.blob.core.windows.net/umbraco-assets-corp/39339/activity-report-2025-2026-final.pdf. (Accessed: 27 October 2026).
19. Hopkinson C, Curnow E, Larkin DFP, et al. Graphical comparison of surgeon outcomes for the audit of a national corneal transplant registry (OTAG study 32). Eye (Lond). 2023;37(6):1236-41.
20. Wong YL, Liu S, Walkden A. Current perspectives on corneal transplantation (Part 2). Clin Ophthalmol. 2022;16:647-59.
